Eurofins-Cerep Logo

Eurofins-Cerep

Contract research organization for pre-clinical in vitro drug discovery services.

ALECR | PA

Overview

Corporate Details

ISIN(s):
FR0004042232 (+3 more)
LEI:
9695004C9D3ZX7FTZY16
Country:
France
Address:
2 RUE DU PROFESSEUR GARGOUIL, 86600 CELLE-LEVESCAULT

Description

Eurofins-Cerep is a Contract Research Organization (CRO) specializing in pre-clinical drug discovery services. The company provides solutions for in vitro drug profiling and screening in pharmacology, supporting pharmaceutical, biopharmaceutical, and biotechnology companies in the early stages of new drug development. Its services focus on delivering critical data regarding the biological activity and potential liabilities of chemical compounds, which aids clients in the identification and optimization of promising drug candidates before they proceed to clinical trials.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2019-04-29 00:00
rapport annuel 2018
French 5.2 MB
2018-05-02 08:57
Rapport financier annuel 2017
French 1.4 MB
2017-04-28 19:00
RAPPORT FINANCIER ANNUEL
French 1.6 MB
2017-01-27 18:20
Eurofins-Cerep annonce la fin de la période de regroupement d'actions
French 367.5 KB
2016-10-26 19:03
Rapport Financier Semestriel - 1er semestre 2016
French 506.8 KB
2016-04-29 21:30
RAPPORT FINANCIER ANNUEL
French 11.0 MB
2015-10-29 11:43
RAPPORT FINANCIER SEMESTRIEL - SEMESTRE CLOS LE 30 JUIN 2015
French 557.7 KB
2015-10-28 19:00
Eurofins-Cerep annonce ses résultats du 1er semestre 2015
French 237.1 KB
2015-05-27 13:29
RAPPORT ANNUEL 2014
French 1.5 MB
2015-01-14 15:00
Avis préalable à la mise en vente d'actions non réclamées
French 193.4 KB
2015-01-14 14:21
Avis de regroupement d'actions (BALO du 17 décembre 2014 - Bulletin n° 151)
French 120.4 KB
2014-04-30 16:15
Rapport Annuel 2013
French 2.2 MB
2010-03-29 15:00
2009 consolidated results / Positive EBITDA in the second half
English 169.7 KB
2010-03-26 19:00
Résultats consolidés 2009 : un EBE positif au second semestre
French 181.8 KB
2010-03-19 08:00
Introduction aujourd’hui de Cerep sur Alternext
French 110.1 KB

Automate Your Workflow. Get a real-time feed of all Eurofins-Cerep filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Eurofins-Cerep

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Eurofins-Cerep via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

GeneOne Life Science, Inc. Logo
Biopharmaceutical R&D company specializing in nucleic acid-based biomedicines.
South Korea
011000
Geneuro Logo
Develops therapies for neurological and autoimmune diseases by targeting HERVs.
Switzerland
GEM
GENFIT Logo
Develops therapies and diagnostics for patients with rare and severe liver diseases.
France
GNFT
GENFLOW BIOSCIENCES PLC Logo
A biotechnology company developing gene therapies that target the aging process.
United Kingdom
GENF
GENINCODE PLC Logo
Specializes in genetic risk assessment and prediction of cardiovascular disease.
United Kingdom
GENI
GENINUS Inc. Logo
A biotech company offering genomic analysis for precision medicine and drug development.
South Korea
389030
Genomed Spolka Akcyjna Logo
Biotechnology firm for genetic research and molecular diagnostics using NGS technology.
Poland
GEN
A molecular diagnostics company developing tests for the early detection of cancer.
South Korea
228760
Genomic Vision Logo
Provides DNA analysis and quality control for bioproduction and gene therapy.
France
GV
genOway Logo
Designs and develops genetically modified preclinical models for research.
France
ALGEN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.